JOHN BOTSON
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology
- Where
- ANCHORAGE, AK
- NPI
- 1881700334
- Received
- $2,213,180 in 1,259 records, 2019 to 2025 ($2,208,316 general, $4,864 research)
- As principal investigator
- $2,143,347 of research payments to others in 40 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 153 | $129,209 |
| 2025 | Research payment | 1 | $4,864 |
| 2024 | General payment | 226 | $204,479 |
| 2023 | General payment | 194 | $171,402 |
| 2022 | General payment | 190 | $1,159,357 |
| 2021 | General payment | 139 | $121,669 |
| 2020 | General payment | 97 | $110,195 |
| 2019 | General payment | 259 | $312,001 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Horizon Therapeutics plc | 490 | $1,667,604 | 2019–2023 |
| Amgen Inc. | 243 | $290,589 | 2020–2025 |
| ABBVIE INC. | 138 | $78,331 | 2019–2025 |
| Novartis Pharmaceuticals Corporation | 136 | $68,217 | 2019–2025 |
| ANI Pharmaceuticals, Inc. | 43 | $34,024 | 2022–2025 |
| Lilly USA, LLC | 50 | $24,363 | 2019–2025 |
| Celgene Corporation | 21 | $16,381 | 2019 |
| SOBI, INC | 12 | $8,905 | 2024–2025 |
| Eli Lilly and Company | 3 | $7,237 | 2021–2025 |
| PFIZER INC. | 17 | $6,691 | 2019–2025 |
| Aurinia Pharma U.S., Inc. | 6 | $5,725 | 2021–2023 |
| AstraZeneca Pharmaceuticals LP | 24 | $2,692 | 2022–2025 |
| Janssen Biotech, Inc. | 29 | $979 | 2021–2025 |
| GlaxoSmithKline, LLC. | 15 | $475 | 2019–2025 |
| UCB, Inc. | 9 | $256 | 2021–2025 |
| Regeneron Healthcare Solutions, Inc. | 5 | $209 | 2019 |
| Mallinckrodt Hospital Products Inc. | 4 | $181 | 2023–2025 |
| Alexion Pharmaceuticals, Inc. | 3 | $76 | 2023–2024 |
| GENZYME CORPORATION | 3 | $72 | 2023–2025 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 | 2023–2024 |
| Radius Health, Inc. | 1 | $27 | 2023 |
| Genentech USA, Inc. | 1 | $25 | 2024 |
| KYOWA KIRIN, INC. | 1 | $24 | 2025 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 | 2025 |
| Welch Allyn | 1 | $19 | 2020 |
| Kiniksa Pharmaceuticals International, plc | 1 | $15 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Royalty or License | 1 | $1,000,000 |
| Honoraria | 176 | $534,822 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 143 | $343,457 |
| Consulting Fee | 56 | $194,769 |
| Travel and Lodging | 252 | $109,195 |
| Food and Beverage | 622 | $26,008 |
| Research payment | 1 | $4,864 |
| Education | 7 | $44 |
| Gift | 1 | $19 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-23 | Amgen Inc. | $4,864 | Research payment | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | P4 Uncontrolled Gout FORWARD | 2025 |
| 2025-12-22 | SOBI, INC | $7,659 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-22 | ABBVIE INC. | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-20 | Novartis Pharmaceuticals Corporation | $25 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-12-18 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-12-17 | ABBVIE INC. | $3,675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-12-17 | Amgen Inc. | $28 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-17 | Amgen Inc. | $27 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-15 | ABBVIE INC. | $2,625 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-10 | Amgen Inc. | $17 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-12-04 | SOBI, INC | $545 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-04 | SOBI, INC | $315 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-04 | SOBI, INC | $49 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-04 | SOBI, INC | $34 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-04 | SOBI, INC | $32 | Travel and Lodging | Cash or cash equivalent | 2025 | ||
| 2025-12-04 | SOBI, INC | $15 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-03 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-12-01 | ABBVIE INC. | $620 | Travel and Lodging | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-11-20 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-20 | Janssen Biotech, Inc. | $27 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-11-18 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-11-18 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-11-11 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-10-27 | Mallinckrodt Hospital Products Inc. | $24 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-26 | Mallinckrodt Hospital Products Inc. | $122 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-26 | AstraZeneca Pharmaceuticals LP | $39 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-10-26 | Mallinckrodt Hospital Products Inc. | $18 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2025 | |
| 2025-10-25 | ANI Pharmaceuticals, Inc. | $168 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-25 | Novartis Pharmaceuticals Corporation | $118 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-10-25 | ANI Pharmaceuticals, Inc. | $69 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-25 | ANI Pharmaceuticals, Inc. | $44 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-24 | Amgen Inc. | $38 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-23 | Amgen Inc. | $770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-10-23 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-23 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-10-22 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-10-16 | ANI Pharmaceuticals, Inc. | $7 | Education | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-10-10 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-30 | Eli Lilly and Company | $2,725 | Consulting Fee | Cash or cash equivalent | TALTZ Drug, Immunology | 2025 | |
| 2025-09-30 | Amgen Inc. | $90 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-30 | Amgen Inc. | $59 | Food and Beverage | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-30 | Amgen Inc. | $48 | Travel and Lodging | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-29 | Amgen Inc. | $63 | Travel and Lodging | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-23 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-23 | Amgen Inc. | $770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-23 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2025 | |
| 2025-09-18 | Amgen Inc. | $135 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2025 | |
| 2025-09-17 | ANI Pharmaceuticals, Inc. | $1,575 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-09-11 | Novartis Pharmaceuticals Corporation | $6 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-09-09 | Amgen Inc. | $564 | Travel and Lodging | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-09 | Amgen Inc. | $537 | Travel and Lodging | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-09 | Amgen Inc. | $387 | Travel and Lodging | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-08 | Amgen Inc. | $125 | Food and Beverage | In-kind items and services | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-09-05 | Janssen Biotech, Inc. | $118 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-09-05 | ANI Pharmaceuticals, Inc. | $65 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-09-04 | Amgen Inc. | $22 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-28 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-08-20 | Amgen Inc. | $5 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-08-19 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2025 | |
| 2025-08-05 | ANI Pharmaceuticals, Inc. | $7 | Education | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-19 | Janssen Biotech, Inc. | $8 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-06-19 | Janssen Biotech, Inc. | $5 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-06-17 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-13 | Amgen Inc. | $32 | Travel and Lodging | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-13 | Amgen Inc. | $13 | Food and Beverage | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-06-03 | SOBI, INC | $27 | Food and Beverage | In-kind items and services | Kineret Drug, Immunology | 2025 | |
| 2025-06-02 | ANI Pharmaceuticals, Inc. | $5,512 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-02 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-06-02 | ANI Pharmaceuticals, Inc. | $1,312 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-02 | ANI Pharmaceuticals, Inc. | $525 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-02 | ANI Pharmaceuticals, Inc. | $45 | Travel and Lodging | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-06-02 | ANI Pharmaceuticals, Inc. | $38 | Food and Beverage | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-30 | ABBVIE INC. | $1,801 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-30 | Amgen Inc. | $113 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-30 | ABBVIE INC. | $69 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-30 | ABBVIE INC. | $48 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-30 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-28 | Amgen Inc. | $81 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-26 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-05-20 | Amgen Inc. | $7,700 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-20 | Amgen Inc. | $3,850 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-17 | GlaxoSmithKline, LLC. | $25 | Food and Beverage | In-kind items and services | BENLYSTA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-17 | Novartis Pharmaceuticals Corporation | $23 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-05-15 | ABBVIE INC. | $679 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $346 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $80 | Travel and Lodging | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $70 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $60 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-15 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2025 | |
| 2025-05-12 | Amgen Inc. | $5,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-12 | Amgen Inc. | $5,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-12 | Amgen Inc. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-12 | Amgen Inc. | $3,850 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-05-12 | GlaxoSmithKline, LLC. | $17 | Food and Beverage | In-kind items and services | BENLYSTA Biological, IMMUNOLOGY | 2025 | |
| 2025-05-06 | ANI Pharmaceuticals, Inc. | $469 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-06 | ANI Pharmaceuticals, Inc. | $80 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-06 | Amgen Inc. | $19 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-05-02 | ANI Pharmaceuticals, Inc. | $4,987 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-02 | ANI Pharmaceuticals, Inc. | $1,575 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-02 | ANI Pharmaceuticals, Inc. | $176 | Travel and Lodging | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-05-02 | ANI Pharmaceuticals, Inc. | $6 | Food and Beverage | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-29 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-26 | Amgen Inc. | $149 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-04-25 | Amgen Inc. | $743 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-25 | Amgen Inc. | $405 | Travel and Lodging | In-kind items and services | 2025 | ||
| 2025-04-23 | Amgen Inc. | $1,540 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-23 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2025 | |
| 2025-04-15 | PFIZER INC. | $1,250 | Consulting Fee | Cash or cash equivalent | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-04-09 | ANI Pharmaceuticals, Inc. | $617 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-09 | ANI Pharmaceuticals, Inc. | $315 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-09 | ANI Pharmaceuticals, Inc. | $288 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-09 | ANI Pharmaceuticals, Inc. | $80 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-09 | KYOWA KIRIN, INC. | $24 | Food and Beverage | In-kind items and services | CRYSVITA Drug, FIBROBLAST GROWTH FACTOR 23 FGF23 BLOCKING ANTIBODY | 2025 | |
| 2025-04-09 | Amgen Inc. | $4 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-07 | ANI Pharmaceuticals, Inc. | $121 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-04-04 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-04-02 | ANI Pharmaceuticals, Inc. | $525 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-03-29 | Amgen Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-29 | E.R. Squibb & Sons, L.L.C. | $19 | Food and Beverage | Cash or cash equivalent | ORENCIA Biological, Immunology | 2025 | |
| 2025-03-27 | Amgen Inc. | $962 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2025 | ||
| 2025-03-26 | Amgen Inc. | $32 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-19 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-19 | Amgen Inc. | $3,080 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-14 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-13 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-03-12 | GENZYME CORPORATION | $28 | Food and Beverage | In-kind items and services | KEVZARA Biological, Rheumatology | 2025 | |
| 2025-03-06 | Lilly USA, LLC | $15 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2025 | |
| 2025-03-06 | Novartis Pharmaceuticals Corporation | $11 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-02-24 | PFIZER INC. | $16 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-02-20 | ANI Pharmaceuticals, Inc. | $3 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-02-19 | SOBI, INC | $147 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-19 | Novartis Pharmaceuticals Corporation | $17 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-02-19 | SOBI, INC | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-13 | Amgen Inc. | $1,540 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UPLIZNA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-13 | Novartis Pharmaceuticals Corporation | $47 | Food and Beverage | In-kind items and services | ILARIS Drug, Immunology | 2025 | |
| 2025-02-12 | Novartis Pharmaceuticals Corporation | $650 | Consulting Fee | Cash or cash equivalent | COSENTYX Drug, Dermatology | 2025 | |
| 2025-02-12 | PFIZER INC. | $80 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2025 | |
| 2025-02-12 | AstraZeneca Pharmaceuticals LP | $46 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-11 | Janssen Biotech, Inc. | $44 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2025 | |
| 2025-02-11 | Novartis Pharmaceuticals Corporation | $18 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-02-06 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EVENITY Biological, Bone Health | 2025 | |
| 2025-02-04 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-04 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-04 | AstraZeneca Pharmaceuticals LP | $73 | Food and Beverage | In-kind items and services | SAPHNELO Biological, Inflammation and Autoimmunity | 2025 | |
| 2025-02-03 | Amgen Inc. | $16 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-02-03 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-30 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2025 | |
| 2025-01-21 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2025 | |
| 2025-01-15 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-15 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | ENBREL Biological, Inflammation | 2025 | |
| 2025-01-14 | ANI Pharmaceuticals, Inc. | $2,887 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2025 | |
| 2025-01-14 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2025-01-14 | Amgen Inc. | $1,155 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2025 | |
| 2024-12-30 | ABBVIE INC. | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-12-21 | GlaxoSmithKline, LLC. | $24 | Food and Beverage | In-kind items and services | BENLYSTA Biological, IMMUNOLOGY | 2024 | |
| 2024-12-19 | ANI Pharmaceuticals, Inc. | $18 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-12-18 | Janssen Biotech, Inc. | $21 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-12-17 | Amgen Inc. | $8,470 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-17 | Amgen Inc. | $3,850 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-17 | Amgen Inc. | $48 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-17 | Amgen Inc. | $10 | Food and Beverage | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-12-16 | PFIZER INC. | $29 | Food and Beverage | In-kind items and services | XELJANZ Drug, GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | 2024 | |
| 2024-12-12 | ANI Pharmaceuticals, Inc. | $16 | Food and Beverage | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-12-12 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2024 | |
| 2024-12-06 | Amgen Inc. | $1,988 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-12-06 | Amgen Inc. | $265 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-12-06 | Amgen Inc. | $149 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-06 | Amgen Inc. | $141 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-04 | UCB, Inc. | $17 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2024 | |
| 2024-12-03 | Alexion Pharmaceuticals, Inc. | $23 | Food and Beverage | In-kind items and services | STRENSIQ Biological, Rare Disease | 2024 | |
| 2024-11-27 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-25 | ABBVIE INC. | $1,050 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | RINVOQ Biological, IMMUNOLOGY | 2024 | |
| 2024-11-16 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-16 | Novartis Pharmaceuticals Corporation | $4 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2024 | |
| 2024-11-13 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2024 | |
| 2024-11-13 | Amgen Inc. | $7 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-11-06 | Janssen Biotech, Inc. | $26 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-11-05 | ANI Pharmaceuticals, Inc. | $5,250 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-11-05 | ANI Pharmaceuticals, Inc. | $72 | Travel and Lodging | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-11-05 | ANI Pharmaceuticals, Inc. | $8 | Food and Beverage | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-11-04 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-31 | Amgen Inc. | $4,620 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-29 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-29 | Amgen Inc. | $26 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-29 | Amgen Inc. | $6 | Food and Beverage | In-kind items and services | TEPEZZA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-28 | Amgen Inc. | $121 | Food and Beverage | In-kind items and services | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-25 | Janssen Biotech, Inc. | $13 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-10-25 | Janssen Biotech, Inc. | $4 | Food and Beverage | In-kind items and services | TREMFYA Drug, Immunology | 2024 | |
| 2024-10-23 | UCB, Inc. | $20 | Food and Beverage | In-kind items and services | Bimzelx Biological, Immunology | 2024 | |
| 2024-10-21 | ANI Pharmaceuticals, Inc. | $1,575 | Honoraria | Cash or cash equivalent | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-10-15 | Amgen Inc. | $1,540 | Consulting Fee | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-09 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | SKYRIZI Biological, IMMUNOLOGY | 2024 | |
| 2024-10-03 | Novartis Pharmaceuticals Corporation | $12 | Food and Beverage | In-kind items and services | COSENTYX Drug, Dermatology | 2024 | |
| 2024-10-01 | ANI Pharmaceuticals, Inc. | $1,012 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-10-01 | ANI Pharmaceuticals, Inc. | $969 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-10-01 | Amgen Inc. | $219 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-01 | ANI Pharmaceuticals, Inc. | $80 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 | |
| 2024-10-01 | Amgen Inc. | $64 | Travel and Lodging | Cash or cash equivalent | KRYSTEXXA Biological, Inflammation/Rare Disease | 2024 | |
| 2024-10-01 | ANI Pharmaceuticals, Inc. | $43 | Travel and Lodging | In-kind items and services | PURIFIED CORTROPHIN GEL Drug, Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | 2024 |
The latest 200 records of 1,259.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2025-09-24 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $10,166 | P4 Uncontrolled Gout AGILE | 2025 |
| 2025-07-11 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $2,918 | A Randomized, Double-blind, Placebo-controlled Phase 4 Clinical Trial to Evaluate the Long-term Safety and Efficacy of A | 2025 |
| 2025-06-17 | Amgen Inc. | ORTHOALASKA LLCORTHOPEDIC PHYSICIANS ALASKAPRIMARY CARE ASSOCIATES | $4,410 | P4 Uncontrolled Gout AGILE | 2025 |
| 2025-04-24 | Amgen Inc. | ORTHOALASKA LLC | $14,732 | A study to Evaluate the Efficacy and Safety of Dosing KRYSTEXXA (pegloticase) + MTX in Participants | 2025 |
| 2024-11-15 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $3,041 | P4 Uncontrolled Gout AGILE | 2024 |
| 2024-08-27 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $12,620 | Ph4 PMR Avacopan in subjects with ANCA-associated vasculitis CL018_168 | 2024 |
| 2024-07-15 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $335,526 | P4 Uncontrolled Gout FORWARD II | 2024 |
| 2024-05-08 | Amgen Inc. | ORTHOALASKA LLC | $62,743 | P4 Uncontrolled Gout FORWARD II | 2024 |
| 2024-05-02 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $2,000 | Ph2 RCT of Methotrexate to Increase Response in Patients with Uncontrolled Gout Receiving KRYSTEXXA | 2024 |
| 2024-01-31 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $67,882 | Ph4 PMR Avacopan in subjects with ANCA-associated vasculitis CL018_168 | 2024 |
| 2024-01-16 | Amgen Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $29,268 | P4 Uncontrolled Gout AGILE | 2024 |
| 2023-12-21 | Horizon Therapeutics plc | MASSACHUSETTS GENERAL HOSPITAL | $300,902 | INFUSION DURATION STUDY TO ASSESS TOLERABILITY OF PEGLOTICASE ADMINISTERED WITH A SHORTER INFUSION DURATION IN SUBJECTS | 2023 |
| 2023-10-25 | Horizon Therapeutics plc | PROVIDENCE ST JOHNS HEALTH CLINIC | $21,916 | A PHASE 4, OPEN-LABEL STUDY OF KRYSTEXXA (PEGLOTICASE) CO-ADMINISTERED WITH METHOTREXATE (MTX) IN PATIENTS WITH UNCONTRO | 2023 |
| 2022-12-14 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKSA | $280,374 | INFUSION DURATION STUDY TO ASSESS TOLERABILITY OF PEGLOTICASE ADMINISTERED WITH A SHORTER INFUSION DURATION IN SUBJECTS | 2022 |
| 2022-07-06 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $19,375 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPO | 2022 |
| 2022-03-09 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $2,229 | A PHASE 4, OPEN-LABEL STUDY OF KRYSTEXXA? (PEGLOTICASE) CO-ADMINISTERED WITH METHOTREXATE (MTX) IN PATIENTS WITH UNCONTR | 2022 |
| 2021-12-30 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $51,045 | A PHASE 4 OPEN-LABEL STUDY OF KRYSTEXXA (PEGLOTICASE) CO-ADMINISTERED WITH METHOTREXATE (MTX) IN PATIENTS WITH UNCONTROL | 2021 |
| 2021-12-30 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKSA | $147,549 | INFUSION DURATION STUDY TO ASSESS TOLERABILITY OF PEGLOTICASE ADMINISTERED WITH A SHORTER INFUSION DURATION IN SUBJECTS | 2021 |
| 2021-12-16 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $221,170 | A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPONSE | 2021 |
| 2021-07-21 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $30,145 | A MULTICENTER EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPONSE RATES IN PATIENTS WITH UNCONTROLLED GOUT RE | 2021 |
| 2020-12-31 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $45,006 | A MULTICENTER, EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPONSE RATES IN PATIENTS WITH UNCONTROLLED GOUT R | 2020 |
| 2020-10-26 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $371,610 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPO | 2020 |
| 2020-04-01 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $54 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2020 |
| 2020-04-01 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $25 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2020 |
| 2019-12-23 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $92 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $1 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $13 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $126 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $0 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $92 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $65 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $57 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $39 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $23 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $2 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $2 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-25 | Radius Health, Inc. | ORTHOPEDIC PHYSICIANS ALASKA | $139 | A RANDOMIZED, NON-INFERIORITY, PHASE 3, OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABALOPARATI | 2019 |
| 2019-10-23 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA 3801 LAKE OTIS PARKWAY ANCHORAGE AK 99508 | $2,239 | A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPO | 2019 |
| 2019-08-07 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $500 | RETROSPECTIVE, MEDICAL RECORD REVIEW OF SAFETY AND EFFICACY OF KRYSTEXXA WITH OR WITHOUT METHOTREXATE FOR TREATMENT OF C | 2019 |
| 2019-03-06 | Horizon Therapeutics plc | ORTHOPEDIC PHYSICIANS ALASKA | $103,238 | A MULTICENTER, EFFICACY AND SAFETY STUDY OF METHOTREXATE TO INCREASE RESPONSE RATES IN PATIENTS WITH UNCONTROLLED GOUT R | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Anchorage, AK, county Anchorage Municipality, AK, state Alaska; placed by its city name.
| Measure | Place (city or town) Anchorage, AK | County Anchorage Municipality, AK | State Alaska |
|---|---|---|---|
| Population B01003 | 288,976 | 288,976 | 735,706 |
| Population, 2020 census P1 | 291,247 | 291,247 | 733,391 |
| Median age B01002 | 35.2 | 35.2 | 35.8 |
| Under 18 B01001 | 23.5% | 23.5% | 24.1% |
| 65 and over B01001 | 12.9% | 12.9% | 13.8% |
| Households B11001 | 108,597 | 108,597 | 270,533 |
| Foreign born B05002 | 10.9% | 10.9% | 7.7% |
| Median household income B19013 | $103,284 | $103,284 | $92,788 |
| Median family income B19113 | $123,547 | $123,547 | $112,321 |
| Per capita income B19301 | $51,144 | $51,144 | $46,573 |
| Poverty rate B17001 | 8.9% | 8.9% | 10.1% |
| Unemployment rate B23025 | 4.6% | 4.6% | 5.9% |
| Civilian labor force B23025 | 148,419 | 148,419 | 359,445 |
| Mean commute (minutes) B08013 | 18.8 | 18.8 | 19.4 |
| Bachelor's degree or higher B15003 | 38.7% | 38.7% | 31.7% |
| Housing units B25001 | 120,348 | 120,348 | 328,491 |
| Owner-occupied B25003 | 63.9% | 63.9% | 66.8% |
| Renters B25003 | 36.1% | 36.1% | 33.2% |
| Median home value B25077 | $395,900 | $395,900 | $352,900 |
| Median gross rent B25064 | $1,489 | $1,489 | $1,419 |
| White, not Hispanic B03002 | 54.2% | 54.2% | 57.7% |
| Black B03002 | 4.8% | 4.8% | 2.9% |
| Hispanic or Latino B03002 | 9.5% | 9.5% | 7.3% |
| Asian B03002 | 9.8% | 9.8% | 6.4% |
| American Indian and Alaska Native B03002 | 7.0% | 7.0% | 13.2% |
Economy now FRED unemployment 4.3% in Sep 2026 (4.7% a year earlier); per capita personal income $80,510 in 2025, up 30% in five years (+4.6% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Anchorage, AK.
Comments